Saul Centers, Inc.
Saul Centers, Inc. (BFS-PD) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Saul Centers, Inc. (BFS-PD), covering cash flow, earnings, and balance sheets.
Saul Centers, Inc. (BFS-PD) Income Statement & Financial Overview
View the income breakdown for Saul Centers, Inc. BFS-PD across both annual and quarterly reports.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $71.86M | $67.92M | $67.29M | $67.11M |
| Cost of Revenue | $21.73M | $18.90M | $7.62M | $29.27M |
| Gross Profit | $50.13M | $49.03M | $59.67M | $37.85M |
| Gross Profit Ratio | $0.70 | $0.72 | $0.89 | $0.56 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $6.01M | $7.50M | $5.68M | $6.10M |
| Operating Expenses | $20.54M | $21.90M | $5.68M | $18.10M |
| Total Costs & Expenses | $42.26M | $40.80M | $13.30M | $35.54M |
| Interest Income | $0.00 | $0.00 | $0.00 | $38000.00 |
| Interest Expense | $16.75M | $16.77M | $12.21M | $11.72M |
| Depreciation & Amortization | $14.52M | $14.40M | $12.07M | $12.001M |
| EBITDA | $43.54M | $41.53M | $43.34M | $43.58M |
| EBITDA Ratio | $0.61 | $0.61 | $0.64 | $0.65 |
| Operating Income | $29.59M | $27.13M | $53.99M | $31.58M |
| Operating Income Ratio | $0.41 | $0.40 | $0.80 | $0.47 |
| Other Income/Expenses (Net) | -$16.75M | -$16.77M | -$39.51M | -$12.09M |
| Income Before Tax | $12.85M | $10.36M | $14.48M | $19.49M |
| Income Before Tax Ratio | $0.18 | $0.15 | $0.22 | $0.29 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | $9.80M | $8.09M | $14.48M | $14.45M |
| Net Income Ratio | $0.14 | $0.12 | $0.22 | $0.22 |
| EPS | $0.29 | $0.45 | $0.60 | $0.48 |
| Diluted EPS | $0.29 | $0.45 | $0.60 | $0.48 |
| Weighted Avg Shares Outstanding | $24.17M | $24.30M | $24.11M | $24.11M |
| Weighted Avg Shares Outstanding (Diluted) | $24.20M | $24.30M | $24.16M | $24.12M |
Over the past four quarters, Saul Centers, Inc. demonstrated steady revenue growth, increasing from $67.11M in Q2 2024 to $71.86M in Q1 2025. Operating income reached $29.59M in Q1 2025, maintaining a consistent 41% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $43.54M, reflecting operational efficiency. Net income rose to $9.80M, with EPS at $0.29. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan